|
FY2025
12 months to Dec 31, 2025
|
FY2024
11 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustment to reconcile net income (loss) to net cash used in operating activities: | ||
| Stock-based compensation | ||
| Interest earned on demand deposit in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Due to related party – administrative expenses | ||
| Accounts payable and accrued expenses | ||
| Net Cash Used in Operating Activities | ||
| Cash Flows from Investing Activities: | ||
| Purchase of investment held in trust account | ||
| Net Cash Used in Investing Activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of public units | ||
| Proceeds from sale of private placement units | ||
| Payment of underwriter commissions | ||
| Repayment of promissory note - related party | ||
| Payment of operating expenses via promissory note – related party | ||
| Payment of offering costs | ||
| Net Cash Provided by Financing Activities | ||
| Net Change in Cash | ||
| Cash, End of Year | ||
| Supplemental Disclosure of Cash Flow Information: | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of ordinary shares | ||
| Deferred offering costs paid via promissory note – related party | ||
| Accretion of carrying value to redemption value | ||
| Issuance of Representative Shares |
Loading...
